Last update 19 Apr 2025

Semaglutide (Qilu Pharmaceutical)

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
QLG 2065, QLG-2065, QLG2065
Target
GLP-1R
Action
agonists
Mechanism
GLP-1R agonists(Glucagon-like peptide 1 receptor agonists)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication
Diabetes Mellitus, Type 2
Inactive Indication-
Originator Organization
Qilu Pharmaceutical Co., Ltd.Qilu Pharmaceutical Co., Ltd.
Active Organization
Qilu Pharmaceutical Co., Ltd.Qilu Pharmaceutical Co., Ltd.
Inactive Organization-
Drug Highest PhaseNDA/BLA
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with Semaglutide (Qilu Pharmaceutical)
CTR20230841
/ CompletedPhase 3
评估司美格鲁肽注射液（QLG2065）对比诺和泰®对于二甲双胍治疗后血糖控制不佳的2型糖尿病患者的有效性和安全性Ⅲ期研究
[Translation] Phase III study to evaluate the efficacy and safety of semaglutide injection (QLG2065) compared with Novotel® in patients with type 2 diabetes who have poor glycemic control after metformin treatment
NCT05950516
/ Not yet recruitingPhase 3
Efficacy and Safety of Semaglutide Injection (QLG2065) vs. Ozempic® as add-on to Metformin in Type 2 Diabetics.
CTR20230548
/ CompletedNot Applicable
司美格鲁肽注射液人体药代动力学研究
[Translation] Study on the pharmacokinetics of semaglutide injection in healthy volunteers
100 Clinical Results associated with Semaglutide (Qilu Pharmaceutical)
Login to view more data
100 Translational Medicine associated with Semaglutide (Qilu Pharmaceutical)
Login to view more data
100 Patents (Medical) associated with Semaglutide (Qilu Pharmaceutical)
Login to view more data
100 Deals associated with Semaglutide (Qilu Pharmaceutical)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2NDA/BLA
China
Qilu Pharmaceutical Co., Ltd.Qilu Pharmaceutical Co., Ltd.
15 Sep 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free